Yoshitaka Kasai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yoshitaka Kasai has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Hiroyasu Yokomise
Department of General Thoracic, Breast and Endocrinological Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan
6 shared publications Shinya Ishikawa
Department of Thoracic Surgery, Tenri Hospital, Tenri, Japan
5 shared publicationsJun Nakano
4 shared publications- Masaya Okuda
Department of General Thoracic Surgery, Faculty of Medicine, Kagawa University, Kita-Gun, Japan
4 shared publications Dage Liu
Second Department of Surgery, Faculty of Medicine, Kagawa University
3 shared publicationsNatsumi Mori
Second Department of Surgery, Faculty of Medicine, Kagawa University
3 shared publications
Latest Publications
- 1 April 2015
- Vol. 68 (4) , 262-5
[Perioperative Management of Lung Cancer Patients with atrial fibrillation being treated by antiplatelet or anticoagulant therapy].
In an aging society, the high incidence of surgery for the patients with ischemic heart disease(IHD)or atrial fibrillation(Af) under antiplatelet or anticoagulant therapy is a great problem. Interruption of antiplatelet or anticoagulant oral agents in the perioperative period may increase the risk of coronary or cerebral events. We retrospectively reviewed the surgical outcomes for lung cancer patients with IHD or Af. We reviewed 135 patients with lung cancer(41~88 years;97 men) who had preoperative oral administration of antiplatelet or anticoagulant drugs for IHD or Af between 2005 and 2012 at 2 centers, and analyzed retrospectively the perioperative medications and complications. IHD, Af and vasospastic angina(VSA) were complicated in 94, 33 and 8 patients, respectively. Drugeluted and bare-metal stents had been placed in 18 and 19 patients. Oral agents were aspirin in 68 patients, ticlopidine in 10 patients, clopidogrel in 15 patients and warfarin in 25 patients. These agents were stopped 2 to 60 days before surgery. Perioperative heparinization was performed in 22 patients. Oral agents were restarted after confirmation of hemostasis and no need for further invasive treatment. The surgical procedures were lobectomy in 88 patients, segmentectomy in 19 and partial resection in 25. There were no hemorrhagic or thromboembolic complications in a perioperative period except 1 case of pulmonary hemorrhage and 1 case of cerebral infarction. No perioperative hospital death was documented. Short-term interruption of antiplatelet or anticoagulant drugs before lung cancer surgery and heparinization was acceptable from the view of perioperative outcomes.
- 1 April 2015
- Vol. 68 (4) , 262-5
[Perioperative Management of Lung Cancer Patients with atrial fibrillation being treated by antiplatelet or anticoagulant therapy].
In an aging society, the high incidence of surgery for the patients with ischemic heart disease(IHD)or atrial fibrillation(Af) under antiplatelet or anticoagulant therapy is a great problem. Interruption of antiplatelet or anticoagulant oral agents in the perioperative period may increase the risk of coronary or cerebral events. We retrospectively reviewed the surgical outcomes for lung cancer patients with IHD or Af. We reviewed 135 patients with lung cancer(41~88 years;97 men) who had preoperative oral administration of antiplatelet or anticoagulant drugs for IHD or Af between 2005 and 2012 at 2 centers, and analyzed retrospectively the perioperative medications and complications. IHD, Af and vasospastic angina(VSA) were complicated in 94, 33 and 8 patients, respectively. Drugeluted and bare-metal stents had been placed in 18 and 19 patients. Oral agents were aspirin in 68 patients, ticlopidine in 10 patients, clopidogrel in 15 patients and warfarin in 25 patients. These agents were stopped 2 to 60 days before surgery. Perioperative heparinization was performed in 22 patients. Oral agents were restarted after confirmation of hemostasis and no need for further invasive treatment. The surgical procedures were lobectomy in 88 patients, segmentectomy in 19 and partial resection in 25. There were no hemorrhagic or thromboembolic complications in a perioperative period except 1 case of pulmonary hemorrhage and 1 case of cerebral infarction. No perioperative hospital death was documented. Short-term interruption of antiplatelet or anticoagulant drugs before lung cancer surgery and heparinization was acceptable from the view of perioperative outcomes.
- 1 July 2014
- Vol. 67 (8) , 758-63
[Infrared thoracoscopy].
Infrared thoracoscopy with indocyanine green (ICG) is a new method of evaluating lung perfusion. We succeeded in visualizing lung emphysematous lesions and intersegmental borders using infrared thoracoscopy with ICG in animals, and within clinical investigations. There are 2 methods in infrared thoracoscopy. One is the 2-wavelength method, and the other is the 1-wavelength method. The 2- wavelength method is based on ICG absorption, and the 1-wavelength method is based on ICG fluorescence. The 2-wavelength method is superior for the clarity of images. On the other hand, the 1-wavelength method is superior for the duration of staining and the dose of ICG. Commonly, the inflation and deflation line has been used to identify the intersegmental border, but lung reinflation narrows the surgical view and can lead to prolongation of operation time, particularly in the context of video-assisted thoracic surgery (VATS). Infrared thoracoscopy with ICG is based on blood flow rather than on ventilation and can thus achieve anatomical segmentectomy without lung reinflation. This article closely reviews the principle and usefulness of infrared thoracoscopy, and difference between 2- and 1- wavelength method.
- 1 July 2014
- Vol. 67 (8) , 758-63
[Infrared thoracoscopy].
Infrared thoracoscopy with indocyanine green (ICG) is a new method of evaluating lung perfusion. We succeeded in visualizing lung emphysematous lesions and intersegmental borders using infrared thoracoscopy with ICG in animals, and within clinical investigations. There are 2 methods in infrared thoracoscopy. One is the 2-wavelength method, and the other is the 1-wavelength method. The 2- wavelength method is based on ICG absorption, and the 1-wavelength method is based on ICG fluorescence. The 2-wavelength method is superior for the clarity of images. On the other hand, the 1-wavelength method is superior for the duration of staining and the dose of ICG. Commonly, the inflation and deflation line has been used to identify the intersegmental border, but lung reinflation narrows the surgical view and can lead to prolongation of operation time, particularly in the context of video-assisted thoracic surgery (VATS). Infrared thoracoscopy with ICG is based on blood flow rather than on ventilation and can thus achieve anatomical segmentectomy without lung reinflation. This article closely reviews the principle and usefulness of infrared thoracoscopy, and difference between 2- and 1- wavelength method.
- 1 December 2013
- Vol. 33 (12) , 5597-602
Chemotherapy followed by surgery on the basis of biomarker examination for patients with advanced non-small cell lung cancer.
We have previously reported that low expression of excision repair cross-complementing-1 (ERCC1), class III β-tubulin (tubulin), thymidylate synthase (TYMS) and ribonucleotide reductase-M1 (RRM1) is indicative of a favorable prognosis in patients with c-N2,3 non-small cell lung cancer (NSCLC) treated with surgery after induction chemoradiotherapy. In the present study, we prospectively explored the tailor-made treatment menu for induction chemotherapy according to the status of biomarkers, and evaluated the biomarker status pre- and post-chemotherapy. Twenty-five patients with pathologically-proven NSCLC who were not appropriate candidates for initial surgery were enrolled (October 2010 to June 2012, stage IIIA/B/IV1a/1b;14/5/2/4 respectively). Immunohistochemistry was performed to evaluate intratumoral expression of biomarkers. Epidermal growth factor receptor (EGFR) mutation was evaluated by direct sequencing. Two to four cycles of chemotherapy were performed with or without concurrent radiation (50 Gy). Docetaxel (n=12), pemetrexed (n=4), S-1 (n=4), docetaxel-plus-bevacizumab (n=3), and pemetrexed-plus-bevacizumab (n=2), in combination with platinum were selected for the therapeutic regimen. Twenty-one (84.0%) patients exhibited good partial response, and underwent complete resection without major morbidity or mortality. Of these 21 patients, four achieved a pathologically-complete response (PCR), and 10 achieved a major pathological response. The 3-year overall survival rate was 58.7% for the 25 patients overall, and the 2-year overall survival rate was 73.6% for patients who underwent surgery. Among the 17 patients who underwent resection (except for four with PCR), the status of ERCC1, tubulin, TYMS, RRM1 and EGFR changed markedly after chemotherapy in six patients, eleven patients, eight patients, nine patients and one patient, respectively. Chemotherapy followed by surgery on the basis of biomarker examination is a challenging approach for patients with advanced NSCLC who otherwise have poor outcomes. Post-chemotherapy biomarker status changed markedly in many cases.
- 1 December 2013
- Vol. 33 (12) , 5597-602
Chemotherapy followed by surgery on the basis of biomarker examination for patients with advanced non-small cell lung cancer.
We have previously reported that low expression of excision repair cross-complementing-1 (ERCC1), class III β-tubulin (tubulin), thymidylate synthase (TYMS) and ribonucleotide reductase-M1 (RRM1) is indicative of a favorable prognosis in patients with c-N2,3 non-small cell lung cancer (NSCLC) treated with surgery after induction chemoradiotherapy. In the present study, we prospectively explored the tailor-made treatment menu for induction chemotherapy according to the status of biomarkers, and evaluated the biomarker status pre- and post-chemotherapy. Twenty-five patients with pathologically-proven NSCLC who were not appropriate candidates for initial surgery were enrolled (October 2010 to June 2012, stage IIIA/B/IV1a/1b;14/5/2/4 respectively). Immunohistochemistry was performed to evaluate intratumoral expression of biomarkers. Epidermal growth factor receptor (EGFR) mutation was evaluated by direct sequencing. Two to four cycles of chemotherapy were performed with or without concurrent radiation (50 Gy). Docetaxel (n=12), pemetrexed (n=4), S-1 (n=4), docetaxel-plus-bevacizumab (n=3), and pemetrexed-plus-bevacizumab (n=2), in combination with platinum were selected for the therapeutic regimen. Twenty-one (84.0%) patients exhibited good partial response, and underwent complete resection without major morbidity or mortality. Of these 21 patients, four achieved a pathologically-complete response (PCR), and 10 achieved a major pathological response. The 3-year overall survival rate was 58.7% for the 25 patients overall, and the 2-year overall survival rate was 73.6% for patients who underwent surgery. Among the 17 patients who underwent resection (except for four with PCR), the status of ERCC1, tubulin, TYMS, RRM1 and EGFR changed markedly after chemotherapy in six patients, eleven patients, eight patients, nine patients and one patient, respectively. Chemotherapy followed by surgery on the basis of biomarker examination is a challenging approach for patients with advanced NSCLC who otherwise have poor outcomes. Post-chemotherapy biomarker status changed markedly in many cases.
- Open Access
- 16 July 2013
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 175
Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer
The existence of circulating tumor cells (CTCs) in patients with lung cancer has been reported. The purpose of this study was to assess whether CTCs are predictive of the pathological effects of induction chemoradiotherapy for patients with non-small cell lung cancer.
- 16 July 2013
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 175
Open AccessInnovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer
The existence of circulating tumor cells (CTCs) in patients with lung cancer has been reported. The purpose of this study was to assess whether CTCs are predictive of the pathological effects of induction chemoradiotherapy for patients with non-small cell lung cancer.
- Open Access
- 24 April 2013
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 44 (6) , 1103-1107
Clinical trial of new methods for identifying lung intersegmental borders using infrared thoracoscopy with indocyanine green: comparative analysis of 2- and 1-wavelength methods
Infrared thoracoscopy is a new method of identifying lung intersegmental borders. This study compared the efficacy of 2- and 1-wavelength infrared thoracoscopy. A total of 30 consecutive patients who underwent segmentectomy were evaluated by these methods (2-wavelength method, 10 patients; 1-wavelength method, 20 patients). We ligated the dominant pulmonary artery and then observed the lung using an infrared thoracoscope after indocyanine green (ICG) intravenous injection. The 2-wavelength infrared thoracoscope irradiation and detection were conducted at 940 and 805 nm, respectively, and the images were projected based on the difference of the two reflected wavelengths. ICG absorbs 805 nm wavelength light, and the ICG distribution area appears blue against a white background. On the other hand, the 1-wavelength infrared thoracoscope irradiation and detection were conducted at 780 and 830 nm, respectively. The area stained with ICG shows fluorescence. In the 2-wavelength method, 3.0 mg/kg of ICG was administered, and a well-defined white-to-blue border was observed in 9 of 10 patients. The staining duration was 220 (interquartile range, 187–251) s. In the 1-wavelength method, 0.5 mg/kg of ICG was administered, and a well-defined border between areas with or without fluorescence was observed in 19 of 20 patients. The staining duration was 370 (interquartile range, 296–440) s, which was significantly longer than the staining duration with the 2-wavelength method (P = 0.0001). Infrared thoracoscopy is useful for detection of intersegmental borders. The dose of ICG for the 1-wavelength method was less than that for 2-wavelength method, and the duration of staining was longer.
- 24 April 2013
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 44 (6) , 1103-1107
Open AccessClinical trial of new methods for identifying lung intersegmental borders using infrared thoracoscopy with indocyanine green: comparative analysis of 2- and 1-wavelength methods
Infrared thoracoscopy is a new method of identifying lung intersegmental borders. This study compared the efficacy of 2- and 1-wavelength infrared thoracoscopy. A total of 30 consecutive patients who underwent segmentectomy were evaluated by these methods (2-wavelength method, 10 patients; 1-wavelength method, 20 patients). We ligated the dominant pulmonary artery and then observed the lung using an infrared thoracoscope after indocyanine green (ICG) intravenous injection. The 2-wavelength infrared thoracoscope irradiation and detection were conducted at 940 and 805 nm, respectively, and the images were projected based on the difference of the two reflected wavelengths. ICG absorbs 805 nm wavelength light, and the ICG distribution area appears blue against a white background. On the other hand, the 1-wavelength infrared thoracoscope irradiation and detection were conducted at 780 and 830 nm, respectively. The area stained with ICG shows fluorescence. In the 2-wavelength method, 3.0 mg/kg of ICG was administered, and a well-defined white-to-blue border was observed in 9 of 10 patients. The staining duration was 220 (interquartile range, 187–251) s. In the 1-wavelength method, 0.5 mg/kg of ICG was administered, and a well-defined border between areas with or without fluorescence was observed in 19 of 20 patients. The staining duration was 370 (interquartile range, 296–440) s, which was significantly longer than the staining duration with the 2-wavelength method (P = 0.0001). Infrared thoracoscopy is useful for detection of intersegmental borders. The dose of ICG for the 1-wavelength method was less than that for 2-wavelength method, and the duration of staining was longer.
- 1 January 2013
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 27 (6) , 719-722
A case of intercostal lung hernia from previous thoracotomy space
- 1 January 2013
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 27 (6) , 719-722
A case of intercostal lung hernia from previous thoracotomy space
- Open Access
- 1 January 2006
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 20 (4) , 659-662
A case of adult bronchopulmonary fibrosarcoma
症例は67歳女性.3年前に前医で肺平滑筋腫として左S6の部分切除術を受けた.経過観察中に呼吸不全を発症し,当院に紹介された.胸部CT上,左肺門部を中心に上下葉にまたがる腫瘤陰影を認めた.腫瘍は左主気管支へ進展し,完全切除のために左肺全摘術を施行した.術後病理の検討により,3年前の腫瘍は線維肉腫であり,今回はその局所再発と診断された.成人の気管支肺線維肉腫は比較的稀であるが,局所再発の報告が多く,正確な診断と,十分な切除マージンの確保が重要と考えられた.
- 1 January 2006
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 20 (4) , 659-662
Open AccessA case of adult bronchopulmonary fibrosarcoma
症例は67歳女性.3年前に前医で肺平滑筋腫として左S6の部分切除術を受けた.経過観察中に呼吸不全を発症し,当院に紹介された.胸部CT上,左肺門部を中心に上下葉にまたがる腫瘤陰影を認めた.腫瘍は左主気管支へ進展し,完全切除のために左肺全摘術を施行した.術後病理の検討により,3年前の腫瘍は線維肉腫であり,今回はその局所再発と診断された.成人の気管支肺線維肉腫は比較的稀であるが,局所再発の報告が多く,正確な診断と,十分な切除マージンの確保が重要と考えられた.
- 1 January 2005
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 19 (5) , 705-708
A case of pulmonary cryptococcosis that changed from pure-GGO rapidly on chest CT for 5 months
症例は71歳男性. 他科入院中の胸部HRCTにて, 左肺S4に径10mm大のground-glass opacity (GGO) を指摘された. 胸部HRCTにて経過観察されていたが, 徐々に内部濃度の上昇を認めた. 肺腺癌が強く疑われたため, 2004年6月22日, 診断・治療目的にて, 左肺舌区域切除術を施行し, 肺クリプトコッカス症と診断された. 胸部HRCT上, 肺腺癌との鑑別が困難であった肺クリプトコッカス症の1例を経験した. 急速な変化を示すGGOは, 肺腺癌とともに肺クリプトコッカス症にも注意する必要がある.
- 1 January 2005
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 19 (5) , 705-708
A case of pulmonary cryptococcosis that changed from pure-GGO rapidly on chest CT for 5 months
症例は71歳男性. 他科入院中の胸部HRCTにて, 左肺S4に径10mm大のground-glass opacity (GGO) を指摘された. 胸部HRCTにて経過観察されていたが, 徐々に内部濃度の上昇を認めた. 肺腺癌が強く疑われたため, 2004年6月22日, 診断・治療目的にて, 左肺舌区域切除術を施行し, 肺クリプトコッカス症と診断された. 胸部HRCT上, 肺腺癌との鑑別が困難であった肺クリプトコッカス症の1例を経験した. 急速な変化を示すGGOは, 肺腺癌とともに肺クリプトコッカス症にも注意する必要がある.
- Open Access
- 1 January 2005
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 19 (5) , 697-700
A case of leiomyosarcoma arising from latissimus dorsi muscle
症例は67歳男性. 右背部腫瘤に気付き, 他院にて生検後, 平滑筋肉腫と診断され, 精査加療目的に当科紹介入院となった. 胸部CT, MRIにて腫瘍の大きさは20×15mmで, 右広背筋に局在すると判明した. 手術は, 頭側に5cm, 尾側に10cmの距離を取り, 広範筋筋膜と前鋸筋を含めて切除した. 術後, 50Gyの放射線療法を追加した.平滑筋肉腫は, 主に後腹膜や腸間膜に発生し, 皮膚や皮下組織に発生するものはまれである. 今回我々は, 広背筋に発生したまれな平滑筋肉腫の1例を経験した.
- 1 January 2005
- Published by Japanese Association for Chest Surgery in The Journal of the Japanese Association for Chest Surgery
- Vol. 19 (5) , 697-700
Open AccessA case of leiomyosarcoma arising from latissimus dorsi muscle
症例は67歳男性. 右背部腫瘤に気付き, 他院にて生検後, 平滑筋肉腫と診断され, 精査加療目的に当科紹介入院となった. 胸部CT, MRIにて腫瘍の大きさは20×15mmで, 右広背筋に局在すると判明した. 手術は, 頭側に5cm, 尾側に10cmの距離を取り, 広範筋筋膜と前鋸筋を含めて切除した. 術後, 50Gyの放射線療法を追加した.平滑筋肉腫は, 主に後腹膜や腸間膜に発生し, 皮膚や皮下組織に発生するものはまれである. 今回我々は, 広背筋に発生したまれな平滑筋肉腫の1例を経験した.